Selected research
Market Outlook & Growth Opportunities
Global Biorepository Services Market Outlook and Growth Opportunities 2026
Market perspective
The global Biorepository Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Biorepository Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Biorepository Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Biorepository Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Biorepository Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Biorepository Services market include Azenta, EPL Archives (VWR), Q2 Lab Solutions, Medpace Labs, Thermo Fisher Scientific, Clinigen, Precision Stability Storage, Precision for Medicine and Kryosphere, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Biorepository Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Biorepository Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Biorepository Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Biorepository Services market.
Biorepository Services Segment by Company
Azenta
EPL Archives (VWR)
Q2 Lab Solutions
Medpace Labs
Thermo Fisher Scientific
Clinigen
Precision Stability Storage
Precision for Medicine
Kryosphere
Cryoport Inc
Masy BioServices (Alcami)
SciSafe (BioLife Solutions)
Cenetron (Versiti Clinical Trials)
Vigilant Bioservices
CellCarta
BioArkive
Tescor
Birka BioStorag
Shanghai Biochip Co
Albetra
Biorepository Services Segment by Type
Room Temperature Storage
Refrigerated Storage
Frozen Storage
Ultra Low Temperature Storage
Liquid Nitrogen Storage
Others
Biorepository Services Segment by Application
Life Sciences
Hospital
Research Institutions
Chemical Industry
Others
Biorepository Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Biorepository Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Biorepository Services key companies, revenue, market share, and recent developments.
3. To split the Biorepository Services breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Biorepository Services market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Biorepository Services significant trends, drivers, influence factors in global and regions.
6. To analyze Biorepository Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biorepository Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biorepository Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biorepository Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Biorepository Services industry.
Chapter 3: Detailed analysis of Biorepository Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Biorepository Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Biorepository Services in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Room Temperature Storage
- Refrigerated Storage
- Frozen Storage
- Ultra Low Temperature Storage
- Liquid Nitrogen Storage
- Others
Applications
- Life Sciences
- Hospital
- Research Institutions
- Chemical Industry
- Others
Companies covered
- Azenta
- EPL Archives (VWR)
- Q2 Lab Solutions
- Medpace Labs
- Thermo Fisher Scientific
- Clinigen
- Precision Stability Storage
- Precision for Medicine
- Kryosphere
- Cryoport Inc
- Masy BioServices (Alcami)
- SciSafe (BioLife Solutions)
- Cenetron (Versiti Clinical Trials)
- Vigilant Bioservices
- CellCarta
- BioArkive
- Tescor
- Birka BioStorag
- Shanghai Biochip Co
- Albetra
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Biorepository Services Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Biorepository Services Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Biorepository Services Market Dynamics
- 2.1 Biorepository Services Industry Trends
- 2.2 Biorepository Services Industry Drivers
- 2.3 Biorepository Services Industry Opportunities and Challenges
- 2.4 Biorepository Services Industry Restraints
3 Biorepository Services Market by Company
- 3.1 Global Biorepository Services Company Revenue Ranking in 2025
- 3.2 Global Biorepository Services Revenue by Company (2021-2026)
- 3.3 Global Biorepository Services Company Ranking (2024-2026)
- 3.4 Global Biorepository Services Company Manufacturing Base and Headquarters
- 3.5 Global Biorepository Services Company Product Type and Application
- 3.6 Global Biorepository Services Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Biorepository Services Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Biorepository Services Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Biorepository Services Market by Type
- 4.1 Biorepository Services Type Introduction
- 4.1.1 Room Temperature Storage
- 4.1.2 Refrigerated Storage
- 4.1.3 Frozen Storage
- 4.1.4 Ultra Low Temperature Storage
- 4.1.5 Liquid Nitrogen Storage
- 4.1.6 Others
- 4.2 Global Biorepository Services Sales Value by Type
- 4.2.1 Global Biorepository Services Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Biorepository Services Sales Value by Type (2021-2032)
- 4.2.3 Global Biorepository Services Sales Value Share by Type (2021-2032)
5 Biorepository Services Market by Application
- 5.1 Biorepository Services Application Introduction
- 5.1.1 Life Sciences
- 5.1.2 Hospital
- 5.1.3 Research Institutions
- 5.1.4 Chemical Industry
- 5.1.5 Others
- 5.2 Global Biorepository Services Sales Value by Application
- 5.2.1 Global Biorepository Services Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Biorepository Services Sales Value by Application (2021-2032)
- 5.2.3 Global Biorepository Services Sales Value Share by Application (2021-2032)
6 Biorepository Services Regional Value Analysis
- 6.1 Global Biorepository Services Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biorepository Services Sales Value by Region (2021-2032)
- 6.2.1 Global Biorepository Services Sales Value by Region: 2021-2026
- 6.2.2 Global Biorepository Services Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Biorepository Services Sales Value (2021-2032)
- 6.3.2 North America Biorepository Services Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Biorepository Services Sales Value (2021-2032)
- 6.4.2 Europe Biorepository Services Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Biorepository Services Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Biorepository Services Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Biorepository Services Sales Value (2021-2032)
- 6.6.2 South America Biorepository Services Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Biorepository Services Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Biorepository Services Sales Value Share by Country, 2025 VS 2032
7 Biorepository Services Country-level Value Analysis
- 7.1 Global Biorepository Services Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Biorepository Services Sales Value by Country (2021-2032)
- 7.2.1 Global Biorepository Services Sales Value by Country (2021-2026)
- 7.2.2 Global Biorepository Services Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.7.2 France Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.14.2 China Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.17.2 India Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Biorepository Services Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Biorepository Services Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Biorepository Services Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Biorepository Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Azenta
- 8.1.1 Azenta Company Information
- 8.1.2 Azenta Business Overview
- 8.1.3 Azenta Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.1.4 Azenta Biorepository Services Product Portfolio
- 8.1.5 Azenta Recent Developments
- 8.2 EPL Archives (VWR)
- 8.2.1 EPL Archives (VWR) Company Information
- 8.2.2 EPL Archives (VWR) Business Overview
- 8.2.3 EPL Archives (VWR) Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.2.4 EPL Archives (VWR) Biorepository Services Product Portfolio
- 8.2.5 EPL Archives (VWR) Recent Developments
- 8.3 Q2 Lab Solutions
- 8.3.1 Q2 Lab Solutions Company Information
- 8.3.2 Q2 Lab Solutions Business Overview
- 8.3.3 Q2 Lab Solutions Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.3.4 Q2 Lab Solutions Biorepository Services Product Portfolio
- 8.3.5 Q2 Lab Solutions Recent Developments
- 8.4 Medpace Labs
- 8.4.1 Medpace Labs Company Information
- 8.4.2 Medpace Labs Business Overview
- 8.4.3 Medpace Labs Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.4.4 Medpace Labs Biorepository Services Product Portfolio
- 8.4.5 Medpace Labs Recent Developments
- 8.5 Thermo Fisher Scientific
- 8.5.1 Thermo Fisher Scientific Company Information
- 8.5.2 Thermo Fisher Scientific Business Overview
- 8.5.3 Thermo Fisher Scientific Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.5.4 Thermo Fisher Scientific Biorepository Services Product Portfolio
- 8.5.5 Thermo Fisher Scientific Recent Developments
- 8.6 Clinigen
- 8.6.1 Clinigen Company Information
- 8.6.2 Clinigen Business Overview
- 8.6.3 Clinigen Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.6.4 Clinigen Biorepository Services Product Portfolio
- 8.6.5 Clinigen Recent Developments
- 8.7 Precision Stability Storage
- 8.7.1 Precision Stability Storage Company Information
- 8.7.2 Precision Stability Storage Business Overview
- 8.7.3 Precision Stability Storage Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.7.4 Precision Stability Storage Biorepository Services Product Portfolio
- 8.7.5 Precision Stability Storage Recent Developments
- 8.8 Precision for Medicine
- 8.8.1 Precision for Medicine Company Information
- 8.8.2 Precision for Medicine Business Overview
- 8.8.3 Precision for Medicine Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.8.4 Precision for Medicine Biorepository Services Product Portfolio
- 8.8.5 Precision for Medicine Recent Developments
- 8.9 Kryosphere
- 8.9.1 Kryosphere Company Information
- 8.9.2 Kryosphere Business Overview
- 8.9.3 Kryosphere Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.9.4 Kryosphere Biorepository Services Product Portfolio
- 8.9.5 Kryosphere Recent Developments
- 8.10 Cryoport Inc
- 8.10.1 Cryoport Inc Company Information
- 8.10.2 Cryoport Inc Business Overview
- 8.10.3 Cryoport Inc Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.10.4 Cryoport Inc Biorepository Services Product Portfolio
- 8.10.5 Cryoport Inc Recent Developments
- 8.11 Masy BioServices (Alcami)
- 8.11.1 Masy BioServices (Alcami) Company Information
- 8.11.2 Masy BioServices (Alcami) Business Overview
- 8.11.3 Masy BioServices (Alcami) Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.11.4 Masy BioServices (Alcami) Biorepository Services Product Portfolio
- 8.11.5 Masy BioServices (Alcami) Recent Developments
- 8.12 SciSafe (BioLife Solutions)
- 8.12.1 SciSafe (BioLife Solutions) Company Information
- 8.12.2 SciSafe (BioLife Solutions) Business Overview
- 8.12.3 SciSafe (BioLife Solutions) Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.12.4 SciSafe (BioLife Solutions) Biorepository Services Product Portfolio
- 8.12.5 SciSafe (BioLife Solutions) Recent Developments
- 8.13 Cenetron (Versiti Clinical Trials)
- 8.13.1 Cenetron (Versiti Clinical Trials) Company Information
- 8.13.2 Cenetron (Versiti Clinical Trials) Business Overview
- 8.13.3 Cenetron (Versiti Clinical Trials) Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.13.4 Cenetron (Versiti Clinical Trials) Biorepository Services Product Portfolio
- 8.13.5 Cenetron (Versiti Clinical Trials) Recent Developments
- 8.14 Vigilant Bioservices
- 8.14.1 Vigilant Bioservices Company Information
- 8.14.2 Vigilant Bioservices Business Overview
- 8.14.3 Vigilant Bioservices Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.14.4 Vigilant Bioservices Biorepository Services Product Portfolio
- 8.14.5 Vigilant Bioservices Recent Developments
- 8.15 CellCarta
- 8.15.1 CellCarta Company Information
- 8.15.2 CellCarta Business Overview
- 8.15.3 CellCarta Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.15.4 CellCarta Biorepository Services Product Portfolio
- 8.15.5 CellCarta Recent Developments
- 8.16 BioArkive
- 8.16.1 BioArkive Company Information
- 8.16.2 BioArkive Business Overview
- 8.16.3 BioArkive Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.16.4 BioArkive Biorepository Services Product Portfolio
- 8.16.5 BioArkive Recent Developments
- 8.17 Tescor
- 8.17.1 Tescor Company Information
- 8.17.2 Tescor Business Overview
- 8.17.3 Tescor Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.17.4 Tescor Biorepository Services Product Portfolio
- 8.17.5 Tescor Recent Developments
- 8.18 Birka BioStorag
- 8.18.1 Birka BioStorag Company Information
- 8.18.2 Birka BioStorag Business Overview
- 8.18.3 Birka BioStorag Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.18.4 Birka BioStorag Biorepository Services Product Portfolio
- 8.18.5 Birka BioStorag Recent Developments
- 8.19 Shanghai Biochip Co
- 8.19.1 Shanghai Biochip Co Company Information
- 8.19.2 Shanghai Biochip Co Business Overview
- 8.19.3 Shanghai Biochip Co Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.19.4 Shanghai Biochip Co Biorepository Services Product Portfolio
- 8.19.5 Shanghai Biochip Co Recent Developments
- 8.20 Albetra
- 8.20.1 Albetra Company Information
- 8.20.2 Albetra Business Overview
- 8.20.3 Albetra Biorepository Services Revenue and Gross Margin (2021-2026)
- 8.20.4 Albetra Biorepository Services Product Portfolio
- 8.20.5 Albetra Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst